Menopause full guideline

In summary, a large number of women in the UK experience menopausal symptoms which, in many cases, can significantly affect their quality of life. It is probable that a minority of these women seek medical treatment and for those who do there is considerable variation in the help available, with man...

Full description

Bibliographic Details
Corporate Authors: National Collaborating Centre for Women's and Children's Health (Great Britain), National Institute for Health and Care Excellence (Great Britain)
Format: eBook
Language:English
Published: [London] National Collaborating Centre for Women's and Children's Health 12 November 2015, 2015
Edition:Version 1.5
Series:Clinical guideline : methods, evidence and recommendations
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:In summary, a large number of women in the UK experience menopausal symptoms which, in many cases, can significantly affect their quality of life. It is probable that a minority of these women seek medical treatment and for those who do there is considerable variation in the help available, with many being told that the symptoms will get better with time. Since symptoms may often continue for 7 years or more, this advice is inappropriate and help should be offered where possible. Women need to know about the available options and their risks and benefits, and be empowered to become part of the decision-making process. The need for this guideline was recognised by the Department of Health and aims to provide advice for both healthcare professionals and women regarding the menopause and the way symptom relief can be achieved. It not only covers women who go through the menopause in middle age, but also those with premature ovarian insufficiency (POI) and for whom hormones are not appropriate, including women with, or at high risk of, breast cancer. It covers the diagnosis and optimal clinical management of menopause-related symptoms, including hormonal and non-hormonal therapies. Attention is also given to the contentious issue of the impact of hormone replacement therapy (HRT) on chronic disease prevention, although other, established treatments for cardiovascular disease (CVD) and osteoporosis, in particular, are not covered
Physical Description:1 PDF file (283 pages) illustrations